Pancreatic adenocarcinoma: Clinical Practice Guidelines in Oncology

Margaret A. Tempero, Stephen Behrman, Edgar Ben-Josef, Al B. Benson, John L. Cameron, Ephraim S. Casper, John P. Hoffman, Richard C. Karl, Paula Kim, Wui Jin Koh, Boris W. Kuvshinoff, W. Scott Melvin, Peter Muscarella, Aaron R. Sasson, Stephen Shibata, Dennis C. Shrieve, Mark S. Talamonti, Douglas S. Tyler, Selwyn M. Vickers, Robert S. WarrenChristopher Willett, Robert A. Wolff

Research output: Contribution to journalReview articlepeer-review

39 Scopus citations


Overall, in view of the poor outcome of patients with all stages of pancreatic cancer, the NCCN Panel recommends that investigational options be considered in all phases of disease management. For patients with advanced disease, supportive care may be considered in accordance with the NCCN Palliative Care Guidelines (for the most up-to-date version of this and other guidelines, please visit

Original languageEnglish (US)
Pages (from-to)598-626
Number of pages29
JournalJNCCN Journal of the National Comprehensive Cancer Network
Issue number5
StatePublished - Sep 2005
Externally publishedYes


  • Adenocarcinoma
  • Ductal carcinoma
  • Endoscopic retrograde cholangiopancreatography
  • Gemcitabine
  • NCCN Clinical Practice Guidelines
  • Pancreas
  • Ultrasonography

ASJC Scopus subject areas

  • Oncology


Dive into the research topics of 'Pancreatic adenocarcinoma: Clinical Practice Guidelines in Oncology'. Together they form a unique fingerprint.

Cite this